Anavex Life Sciences Corp (AVXL)

[A_Good_Day_2]

The results we have so far are not inconclusive the way you are describing.

It is a fact that the safety results of the trial (which was the actual reason for the phase 2a trial) were conclusive and complete. Rock-solid safety results.

It is also a fact that the cognitive scores improved for several patients. This improvement was over a very long period of time. Some of these cognition tests can be tainted by placebo effect. However, for those who understand how the tests work, it is a fact that because of the nature of SOME OF THESE cog tests, placebo effect cannot taint the test results.

So, can we say that the scores were inconclusive? Yes and no.

Some of the testing requires a placebo control. Some does not. All of the tests would benefit from a larger sample size, but that doesn't negate the great results we saw.

Bottom line...we have several AD patients who saw amazing results in their personal life. For them the results were conclusive. The upcoming phase 2/3 will erase any lingering doubts.